Michael Meyer
About Michael Meyer
Michael Meyer is the Chief Technology Officer who specializes in artificial intelligence for medical diagnostics, including the development of the LuCED test for early lung cancer detection.
Michael Meyer Chief Technology Officer
Michael Meyer serves as the Chief Technology Officer at VisionGate. In this role, he manages efforts among various technical and clinical groups and provides final technical arbitration. His responsibilities involve coordinating the development and implementation of advanced technologies within the company.
Michael Meyer Research Scientist at TriPath Imaging, Inc.
Before his current position, Michael Meyer worked as a research scientist at TriPath Imaging, Inc. Here, he supervised the development of algorithms aimed at detecting rarely occurring cervical neoplasms and their precursors on Pap smear slides. His work involved significant research and innovation in the field of medical imaging and diagnostics.
Michael Meyer at IBM in Rochester, MN
Prior to his tenure at TriPath Imaging, Inc., Michael Meyer was employed at IBM in Rochester, MN. During his time at IBM, Meyer gained valuable experience in the technology sector, which later contributed to his expertise in artificial intelligence and medical diagnostics.
Michael Meyer's Expertise in Artificial Intelligence
Michael Meyer possesses expertise in artificial intelligence methods, particularly in the development of diagnostic tests. Notably, he has contributed to the development of the LuCED test for early lung cancer detection, leveraging the Cell-CT platform. His work in AI and medical diagnostics has made significant impacts in the early detection of diseases.